GV.PA
Genomic Vision SA
Price:  
0.00 
EUR
Volume:  
38,489,200.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GV.PA EV/EBITDA

-7789.1%
Upside

As of 2024-12-12, the EV/EBITDA ratio of Genomic Vision SA (GV.PA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GV.PA's latest enterprise value is 1.66 mil EUR. GV.PA's TTM EBITDA according to its financial statements is -7.39 mil EUR. Dividing these 2 quantities gives us the above GV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.5x - 8.8x 7.1x
Forward P/E multiples 6.9x - 8.8x 7.1x
Fair Price (0.13) - (0.17) (0.14)
Upside -7597.7% - -9639.3% -7789.1%
0.00 EUR
Stock Price
(0.14) EUR
Fair Price

GV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA